Poster: Methodology - Study Design

Two-stage adaptive designs in nonlinear mixed-effects models: an evaluation by simulation for a pharmacokinetic (PK) and pharmacodynamic (PD) model in oncology

Thursday 16 October, 2025

Objectives: Optimal design in population PKPD is based on prior information on the models and parameters. Adaptive designs [1,2] are…

Read more

Longitudinal dose-response modelling as primary analysis of a clinical study

Thursday 16 October, 2025

Objectives: ANOVA or analysis of covariance (ANCOVA) is commonly used as the primary analysis for clinical studies. For study designs…

Read more

Adaptive optimal design for the concentration tiers in time-kill curve experiments.

Thursday 16 October, 2025

Objectives: In time-kill curve (TKC) modelling, precise estimation of PD parameters is crucial, e.g. to perform reliable simulations. Conventional designs…

Read more

Statistical Power Analysis to Detect Drug-Drug Interaction between Lorezapam and Probenecid in Healthy and Renal-impaired Populations Using PBPK Modelling and the Simcyp R Package

Thursday 16 October, 2025

Objectives: A tool is already available within the Simcyp Simultaor to calculate the power of studies to correctly detect the difference…

Read more

Optimized Reduced Designs of Pharmacokinetic Clinical Trials Utilizing Target Mediated Drug Disposition Models

Thursday 16 October, 2025

Objectives: Monoclonal antibodies (mAbs) may display target mediated drug disposition (TMDD) [1] when target binding notably alters the disposition of the…

Read more

Application of Model-Based Adaptive Optimal Design to determine a recommended dosing regimen for combination therapy in oncology

Thursday 16 October, 2025

Objectives: Phase 1 trials in the context of combination therapy is a complex question differing from the case of single therapy….

Read more

Model-based comparison of alternative study designs in paediatric trials

Thursday 16 October, 2025

Objectives: The adoption of alternative designs can potentially facilitate the realization of paediatric trials, especially when compared to the standard practice….

Read more

Performance of composite and serial study designs for estimation of toxicokinetic parameters.

Thursday 16 October, 2025

Objectives: In rodent studies, microsampling offers opportunity to sample main study animals for toxicokinetic (TK) assessment rather than satellite animals. …

Read more

Synthesising pragmatic and optimal design: NAPPA – a paediatric penicillin population pharmacokinetic study

Thursday 16 October, 2025

Objectives: The Neonatal and Paediatric Pharmacokinetics (PK) of Antimicrobials study, NAPPA, is a multicentre population PK study evaluating six penicillins…

Read more

Concentration-QTc analysis versus Intersection Union Test: sample size considerations for a thorough QT study

Thursday 16 October, 2025

Objectives: Dedicated Thorough QT (TQT) studies are conducted to assess the proarrhythmic potential of non-antiarrhythmic drugs based on evaluating the…

Read more